ABEO
NASDAQ
US
Abeona Therapeutics Inc. - Common Stock
$4.82
▲ +$0.24
(+5.24%)
Vol 767K
8
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$285.6M
P/E
3.5
ROE
78.4%
Margin
27208.3%
D/E
11.53
Beta
1.18
52W
$4–$8
Wall Street Consensus
12 analysts · Apr 20265
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating
Price Chart
Similar Stocks
NBP
NovaBridge Biosciences
$458.9M
AVXL
Anavex Life Sciences Corp
$318.1M
TARA
Protara Therapeutics Inc
$275.2M
CCCC
C4 Therapeutics Inc
$185.1M
ALEC
Alector Inc
$170.3M
EDIT
Editas Medicine Inc
$200.1M
TLSI
TriSalus Life Sciences Inc
$348.8M
CHRS
Coherus Oncology Inc
P/E 1.1
$171.6M
ALXO
ALX Oncology Holdings Inc
$61.3M
Earnings
Beat rate: 50.0%
Next Report
May 13, 2026
EPS Estimate: $-0.36
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.36 | — | — |
| Dec 2025 | $-0.36 | $-0.37 | $-0.01 |
| Sep 2025 | $-0.30 | $-0.10 | +$0.20 |
| Jun 2025 | $-0.39 | $-0.53 | $-0.14 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 77.7% | 77.7% | 77.7% | 77.7% | 78.4% | 78.4% |
| P/E (TTM) | 5.08 | 6.24 | 4.72 | 4.31 | 3.04 | 3.47 |
| Net Margin | 27208.2% | 27208.2% | 27208.2% | 27208.2% | 27208.2% | 27208.2% |
| Gross Margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| D/E Ratio | 11.96 | 11.96 | 11.96 | 11.96 | 11.53 | 11.53 |
| Current Ratio | 6.73 | 6.73 | 6.73 | 6.73 | 9.74 | 9.74 |
Key Ratios
ROA (TTM)
48.0%
P/S (TTM)
713.97
P/B
5.5
EPS (TTM)
$1.11
CF/Share
$-1.97
52W High
$7.54
52W Low
$3.93
$3.93
52-Week Range
$7.54
How does ABEO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ABEO valuation vs Biotechnology peers
P/E ratio
3.5
▼
82%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
714.0
▲
5456%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
5.5
▲
124%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ABEO profitability vs Biotechnology peers
ROE
78.4%
▲
216%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
27208.3%
▲
9588%
above
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
100.0%
▲
27%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
48.0%
▲
203%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
ABEO financial health vs Biotechnology peers
D/E ratio
11.5
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
9.7
▲
119%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.2
▲
21%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ABEO fundamentals radar
ABEO
Peer median
Industry
ABEO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ABEO vs peers: key metrics
Latest News
No related news yet